FAQ

Yasser M Khder

Suggest Changes
Martin Stefanic10
Peter Stopfer10
Wendy R Sanhai10
Mitchell W. Krucoff7
Keith A.A. Fox7
8Freek W.A. Verheugt
7Christopher B. Granger
7Luis M. Ruilope
6Kenichi A. Tanaka
6Jean-Philippe Collet

Filter Results:

  • Full text PDF available (4)

Publication Year

1996
2017
  • This year (2)
  • Last 5 years (6)
  • Last 10 years (8)

Publication Type

Co-author

Journals and Conferences

Learn More
24-hour ambulatory blood-pressure effects of valsartan and hydrochlorothiazide combinations compared with amlodipine in hypertensive patients at increased cardiovascular risk: a VAST sub-study.
BACKGROUND There is a lack of data on the effects of angiotensin-receptor blocker and diuretic combinations on ambulatory blood pressure (ABP) in hypertensive patients with additional cardiovascular… (More)
Effect of small angiokinase inhibitor nintedanib (BIBF 1120) on QT interval in patients with previously untreated, advanced renal cell cancer in an open-label, phase II study
Purpose Some targeted anticancer agents are associated with serious ventricular tachyarrhythmias, which may be predicted by electrocardiographic evaluation of drug-related QT prolongation. We studied… (More)
Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension:…
BACKGROUND Combination therapy with at least 2 antihypertensive agents is usually needed to achieve appropriate blood pressure (BP) control in patients with isolated or predominant systolic… (More)
Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST…
BACKGROUND Recent antihypertensive treatment guidelines recommend greater use of combination therapies. OBJECTIVES The primary objective of this study was to determine whether combination therapy… (More)
The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
Aims Progressive aortic stiffening eventually leads to left ventricular (LV) hypertrophy and heart failure if left untreated. Anti-hypertensive agents have been shown to reverse this to some extent.… (More)
Investigations of the peripheral vascular mechanisms implicated in congestive heart failure by the non-invasive evaluation of radial artery compliance and reactivity.
The viscoelastic, muscular and endothelial components of the vessel wall may be altered in patients with congestive heart failure (CHF). In order to investigate the relative contribution of each of… (More)